secwatch / observer
8-K filed April 1, 2026, 7:59 PM ET ticker ONCY CIK 0001129928
other material confidence high sentiment neutral materiality 0.55

Oncolytics Biotech completes redomestication to Nevada; adopts new equity plan and governance documents

ONCOLYTICS BIOTECH INC

item 1.01item 3.03item 5.03item 5.02item 8.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001104659-26-038272
form_type
8-K
ticker
ONCY
cik
0001129928
company_name
ONCOLYTICS BIOTECH INC
filed_at
2026-04-01T23:59:59+00:00
discovered_at
2026-05-14T18:02:31.988107+00:00
generated_at
2026-05-15T07:56:30.179108+00:00
sec_items
["1.01", "3.03", "5.03", "5.02", "8.01", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.55
calibrated_materiality_score
0.55
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001104659-26-038272
json_url
https://secwatch.observer/filing/0001104659-26-038272.json
markdown_url
https://secwatch.observer/filing/0001104659-26-038272.md
text_url
https://secwatch.observer/filing/0001104659-26-038272.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/tm2610715d1_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

c9a1968f6ba4a562a9a0f9cb6664050d1699ac5d

ONCOLYTICS BIOTECH INC: Filed Articles of Incorporation and adopted Bylaws in connection with domestication from British Columbia to Nevada.

On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

Comparable filings

SAGU

Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE

Shreya Acquisition Group May 11, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.

Comparable filing

On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Filing page SEC filing

MTNE

CH4 Natural Solutions Corporation prices $200M IPO; begins trading on NYSE

CH4 Natural Solutions Corp May 5, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 7.01, 8.01, 9.01

same fact type: governance_change same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.

Comparable filing

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Company’s Amended and Restated Memorandum and Articles of Association (as so amended, the “ Memorandum and Articles ”) were approved on April 30, 2026.

Filing page SEC filing

CAII

Collective Acquisition Corp. II closes $220M IPO; units trade on Nasdaq

Collective Acquisition Corp. II May 4, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.

Comparable filing

On April 28, 2026, in connection with the Offering, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which became effective on April 28, 2026.

Filing page SEC filing

IACQ

Irenic Acquisition Corp. closes $220M IPO; trust funded with $220M for business combination

Irenic Acquisition Corp. April 29, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.

Comparable filing

On April 27, 2026, in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association (the “Amended Charter”), effective the same day.

Filing page SEC filing

CXII

Churchill Capital Corp XII closes upsized $414M SPAC IPO; units trade on Nasdaq

Churchill Capital Corp XII April 29, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.

Comparable filing

On April 27, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 27, 2026.

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 1.01, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.

Comparable filing

On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.

Filing page SEC filing

PSEC

Prospect Capital enters $400M at-the-market preferred stock offering; reclassifies 16M common shares

PROSPECT CAPITAL CORP May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 9.01

same fact type: governance_change same SEC item: 1.01, 3.03, 5.03, 9.01 same event type: other_material similar materiality

This filing

On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.

Comparable filing

On May 8, 2026, in connection with the Offering, the Company filed Articles Supplementary (the “Articles Supplementary”) with the State Department of Assessments and Taxation of Maryland (“SDAT”), reclassifying and designating 16,000,000 authorized and unissued shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), into shares of Series A Preferred Stock.

Filing page SEC filing

JPM

JPMorgan issues $3B of 6.100% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series PP

JPMORGAN CHASE & CO May 7, 2026, 7:59 PM ET other_material Items 3.03, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 3.03, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.

Comparable filing

On May 6, 2026, the Company filed a Certificate of Designations, Powers, Preferences and Rights with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges, qualifications, restrictions and limitations relating to the Series PP Preferred Stock

Filing page SEC filing

Source: SEC EDGAR
accession 0001104659-26-038272
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.